CoChat

Cytotoxicity of Algae Extracts on Normal and Malignant Cells

Open access
Bechelli, Jeremy, Coppage, Myra, Rosell, Karen, Liesveld, Jane · 2011 · Leukemia Research and Treatment

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Algae preparations are commonly used in alternative medicine. We examined the effects of algae extracts on normal hematopoietic cells and leukemia cells. Ethanol extracts were prepared of Dunaliella salina (Dun), Astaxanthin (Ast), Spirulina platensis (Spir), and Aphanizomenon flos-aquae (AFA). Cell viability effects were completed by Annexin staining. Ast and AFA inhibited HL-60 and MV-4-11 whereas Dun and Spir had no effect. Primary AML blasts demonstrated increased apoptosis in AFA. Primary CLL cells showed apoptosis at 24 hours after exposure to Dun, Ast, Spir, and AFA. High AFA concentrations decreased viability of normal marrow cells. Normal viability was inhibited by Dun. Dun and AFA inhibited BFU-E, but all extracts inhibited CFU-GM. Cell-cycle analysis of AML cell lines showed G0/G1 arrest in the presence of AFA. These data suggest that algae extracts may inhibit AML cell lines and leukemia blasts, but they may also have potential inhibitory effects on normal hematopoiesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4061/2011/373519

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Effects of algae extracts on leukemia cell-line viability. HL60 cells (a) and MV-4-11 cells (b) were treated with algae extracts for 24 hours and analyzed by Annexin V assay for viability. Shown are mean values ± standard errors of three independent experiments (*indicates P < .05).
Figure 1 Effects of algae extracts on leukemia cell-line viability. HL60 cells (a) and MV-4-11 cells (b) were treated with algae extracts for 24 hours and analyzed by Annexin V assay for viability. Shown are mean values ± standard errors of three independent experiments (*indicates P < .05).CC BY · PubMed Central
Figure 2 Viability of primary AML samples treated with algae extracts. Primary leukemic blasts were treated with 8 μl/ml and 15 μl/ml doses of algae extracts for 24 hours and assayed for viability via annexin V staining. Data shown is normalized to conditions with vehicle control added ± standard errors of three independent experiments (*indicates P < .05).
Figure 2 Viability of primary AML samples treated with algae extracts. Primary leukemic blasts were treated with 8 μl/ml and 15 μl/ml doses of algae extracts for 24 hours and assayed for viability via annexin V staining. Data shown is normalized to conditions with vehicle control added ± standard errors of three independent experiments (*indicates P < .05).CC BY · PubMed Central
Figure 3 Viability of primary CLL samples treated with algae extracts. Primary leukemic blasts were treated with 8 μl/ml and 15 μl/ml doses of algae extracts for 24 hours and assayed for viability via annexin V staining. Data shown is normalized to conditions with vehicle control added ± standard errors of four independent experiments (*indicates P < .05).
Figure 3 Viability of primary CLL samples treated with algae extracts. Primary leukemic blasts were treated with 8 μl/ml and 15 μl/ml doses of algae extracts for 24 hours and assayed for viability via annexin V staining. Data shown is normalized to conditions with vehicle control added ± standard errors of four independent experiments (*indicates P < .05).CC BY · PubMed Central
Figure 4 Viability of primary normal bone marrow cells and normal CD34+ cells treated with algae extracts. Primary light density mononuclear cells (a) were treated with 8.0 μl/ml and 15 μl/ml doses of algae extracts for 24 hours and assayed for viability via annexin V staining. Normal CD34+ cells (b) isolated from healthy volunteers were isolated and cultured for 24 hours in the presence of algae extracts and stained for anexin V. Data shown is normalized to conditions with vehicle control ± standard errors of three independent experiments (*indicates P < .05).
Figure 4 Viability of primary normal bone marrow cells and normal CD34+ cells treated with algae extracts. Primary light density mononuclear cells (a) were treated with 8.0 μl/ml and 15 μl/ml doses of algae extracts for 24 hours and assayed for viability via annexin V staining. Normal CD34+ cells (b) isolated from healthy volunteers were isolated and cultured for 24 hours in the presence of algae extracts and stained for anexin V. Data shown is normalized to conditions with vehicle control ± standard errors of three independent experiments (*indicates P < .05).CC BY · PubMed Central
Figure 5 Effect of Algae extracts on day 14 CFU-GM and BFU-E from normal light-density bone marrow. The dose response of algae extracts on colony outgrowth when cultured with methylcellulose and 3 U/ml erythropoietin, 10 ng/ml GM-CSF, 10 ng/ml IL-3, 10 ng/ml IL-6, 10 ng/ml G-CSF, and 50 ng/ml stem-cell factor are shown. Data shown is normalized to conditions with vehicle control ± standard errors of three independent experiments (*indicates P < .05).
Figure 5 Effect of Algae extracts on day 14 CFU-GM and BFU-E from normal light-density bone marrow. The dose response of algae extracts on colony outgrowth when cultured with methylcellulose and 3 U/ml erythropoietin, 10 ng/ml GM-CSF, 10 ng/ml IL-3, 10 ng/ml IL-6, 10 ng/ml G-CSF, and 50 ng/ml stem-cell factor are shown. Data shown is normalized to conditions with vehicle control ± standard errors of three independent experiments (*indicates P < .05).CC BY · PubMed Central
Figure 6 Cell-cycle distribution of HL-60 cells treated with AFA. HL60 cells were cultured with vehicle control (a), 8.0 μl/ml AFA (b), and 15 μl/ml AFA (c), for 24 hours, and DNA was stained with propidium iodide and analyzed by flow cytometry. Data shown is one representative experiment of HL60 cells treated with AFA for 24 hours.
Figure 6 Cell-cycle distribution of HL-60 cells treated with AFA. HL60 cells were cultured with vehicle control (a), 8.0 μl/ml AFA (b), and 15 μl/ml AFA (c), for 24 hours, and DNA was stained with propidium iodide and analyzed by flow cytometry. Data shown is one representative experiment of HL60 cells treated with AFA for 24 hours.CC BY · PubMed Central
Figure 7 Peroxynitrite formation in AML blasts treated with algae extracts. Primary leukemic cells were cultured in the presence of 15 μl/ml of the algae extract for two hours. Cells were labeled with dihydrorhodamine 123 for 20 minutes at room temperature and analyzed by flow cytometry (*indicates P < .05).
Figure 7 Peroxynitrite formation in AML blasts treated with algae extracts. Primary leukemic cells were cultured in the presence of 15 μl/ml of the algae extract for two hours. Cells were labeled with dihydrorhodamine 123 for 20 minutes at room temperature and analyzed by flow cytometry (*indicates P < .05).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 5

  1. 2009, Clinical Advances in Hematology and Oncology, 7, 383
  2. 1995, The British Journal of General Practice, 45, 506
  3. 2008, The Egyptian Journal of Immunology, 15, 161
  4. 2003, Molecular Cancer Therapeutics, 2, 1165
  5. 10.1024/0300-9831.78.4/5.175 · doi:10.1024/0300-9831.78.4/5.175

Cited by

Metadata

Authors
Bechelli, J., Coppage, M., Rosell, K., & Liesveld, J.
Affiliations
University of Rochester Medicine (US)
Corresponding author
Liesveld, Jane
Venue
Leukemia Research and Treatment
Published
2011-01-05
Volume
2011
Pages
1-7
ISSN
  • 2090-3219 (ISSN-L)
  • 2090-3227
OpenAlex
W2008766062
Cited by
52
References
31
Citations by year
2025: 3 · 2024: 5 · 2023: 2 · 2022: 10 · 2021: 3 · 2020: 4 · 2018: 5 · 2017: 3 · 2016: 2 · 2015: 5 · 2014: 1 · 2013: 2 · 2012: 6
FWCI
4.36
Type
journal article
Language
en
Open access
Locations
  • Leukemia Research and Treatment (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Physical Sciences › Chemistry › Organic Chemistry › Phytochemical Studies and Bioactivities
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Medicinal Plant Research
Keywords
algae extract, Dunaliella salina, astaxanthin, Spirulina platensis, Aphanizomenon flos-aquae, acute myeloid leukemia, chronic lymphocytic leukemia, apoptosis, hematopoietic cells, normal hematopoiesis, G0/G1 cell cycle arrest, leukemia cell viability, complementary and alternative medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.